Alymsys C Code: C9142

Drug & Product Overview

HCPCS Descriptor Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg

HCPCS Added Date October 1, 2022

Manufacturer Amneal Biosciences

Route of Administration Intravenous

Generic Status HCPCS Discontinued

Dosage Type Single-Dose

Dosage Form Injection, Solution

About Alymsys

Alymsys is a medication aligned to the HCPCS C Code: C9142 for billing, pricing, and reimbursement purposes in the United States. This Oncology medication is administered via the intravenous route and manufactured by Amneal Biosciences.

Manufacturers, reach out to us to add more information.

NDC Code Information

2 NDC packages are crosswalked to C9142. Package detail is available to logged-in subscribers.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
•••••-••••-•• Log in to view	Alymsys
	Alymsys

Login to view 2 NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

Biosimilar Information

Alymsys Approval Date: April 13, 2022

Product Name	HCPCS Code	Active Ingredient	BLA Type
Avastin	J9035	Bevacizumab	351(a) Originator Product
Mvasi	Q5107	Bevacizumab	351(k) Biosimilar
Zirabev	Q5118	Bevacizumab	351(k) Biosimilar
Alymsys	C9142	Bevacizumab	351(k) Biosimilar
Vegzelma	Q5129	Bevacizumab	351(k) Biosimilar
Avzivi	N/A	Bevacizumab	351(k) Biosimilar
Jobevne	Q5160	Bevacizumab	351(k) Biosimilar

Alymsys CPT Administration Codes

CPT Code	Description
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)

Not on the CMS JW / JZ list

CMS does not include Alymsys (C9142) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing C9142. Wastage billing guide →

Alymsys Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Metastatic Colorectal Cancer Metastatic Renal Cell Carcinoma Non-Squamous Non-Small Cell Lung Cancer Persistent, Recurrent, or Metastatic Cervical Cancer Recurrent Glioblastoma

Drug Class

Vascular Endothelial Growth Factor Inhibitor [EPC]Vascular Endothelial Growth Factor Inhibitors [MoA]Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]

Frequently Asked Questions

Is there an available Alymsys billing and coding guide?

Our team has not identified a manufacturer-published source of billing and coding information for Alymsys.

Are there any available Alymsys patient assistance programs?

Our team has not identified a manufacturer-published source of patient assistance information for Alymsys.

Where can I find Alymsys prescribing information?

Alymsys prescribing information can be found at the link below: Visit Here →

Where can I find Alymsys side effect information?

Information regarding Alymsys's side effects can be found at MedlinePlus Visit Here →

Does billing Alymsys require JZ/JW wastage modifiers?

CMS does not include Alymsys (C9142) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing C9142. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.